CN¥ 30.74
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very poor margins and returns
Data is available to registered users only
Data is available to registered users only
About
Jiangsu Bioperfectus Technologies Co., Ltd. is engaged in the research, development, manufacturing, and marketing of in vitro diagnostic (IVD) solutions across China. The company's core offerings include a range of diagnostic reagents, complementary detection equipment, and comprehensive in vitro testing services. Established in 2010, its operations are based in Taizhou, China.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA, ove
Data is available to registered users only